首页 / 院系成果 / 成果详情页

Effect of Kuanxiong Aerosol on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial  期刊论文  

  • 编号:
    11950426-426e-4ac4-8a65-48cba4e7f5c5
  • 作者:
    Yang Qiaoning#[1]Bai Ruina#[1]Dong Guoju[1];Ge Changjiang[2];Zhou Jingmin[3];Huang Li[4];He Yan(何燕)[5]Wang Jun[6];Ren Aihua[7];Huang Zhanquan[8];Zhu Guangli[9];Lu Shu[10];Xiong Shangquan[11];Xian Shaoxiang[12];Zhu Zhijun[13];Shi Dazhuo[1];Lu Shuzheng[2];Li Lizhi*[1]Chen Keji*[1]
  • 语种:
    英文
  • 期刊:
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE ISSN:1672-0415 2018 年 24 卷 5 期 (336 - 342) ; MAY
  • 收录:
  • 关键词:
  • 摘要:

    Objective: To evaluate the effect and safety of Kuanxiong Aerosol (KA) on patients with angina pectoris. Methods: Block randomization was performed to randomly allocate 750 patients into KA (376 cases) and control groups (374 cases). During an angina attack, the KA group received 3 consecutive sublingual sprays of KA (0.6 mL per spray). The control group received 1 sublingual nitroglycerin tablet (NT, 0.5 mg/tablet). Log-rank tests and Kaplan-Meier estimations were used to estimate the angina remission rates at 6 time-points after treatment (1, 2, 3, 4, 5, and > 5 min). Logistic regression analysis was performed to observe the factors influencing the rate of effective angina remission, and the remission rates and incidences of adverse reactions were compared for different Canadian Cardiovascular Society (CCS) classes of angina. Results: The 5-min remission rates in the KA and control groups were not significantly different (94.41% vs. 90.64%, P > 0.05). The angina CCS class significantly influenced the rate of remission (95% confidence interval = 0.483-0.740, P < 0.01). In the CCS subgroup analysis, the 3- and 5-min remission rates for KA and NT were similar in the CCSII and III subgroups (P > 0.05), while they were significantly better for KA in the CCSI and II subgroups (P < 0.05 or P < 0.01). Furthermore, the incidence of adverse reactions was significantly lower in the KA group than in the control group for the CCSII and III subgroups (9.29% vs. 26.22%, 10.13% vs. 20.88%, P < 0.05 or P < 0.01). Conclusions: KA is not inferior to NT in the remission of angina. Furthermore, in CCSII and III patients, KA is superior to NT, with a lower incidence of adverse reactions.

  • 推荐引用方式
    GB/T 7714:
    Yang Qiao-ning,Bai Rui-na,Dong Guo-ju, et al. Effect of Kuanxiong Aerosol on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial [J].CHINESE JOURNAL OF INTEGRATIVE MEDICINE,2018,24(5):336-342.
  • APA:
    Yang Qiao-ning,Bai Rui-na,Dong Guo-ju,Ge Chang-jiang,&Chen Ke-ji.(2018).Effect of Kuanxiong Aerosol on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial .CHINESE JOURNAL OF INTEGRATIVE MEDICINE,24(5):336-342.
  • MLA:
    Yang Qiao-ning, et al. "Effect of Kuanxiong Aerosol on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial" .CHINESE JOURNAL OF INTEGRATIVE MEDICINE 24,5(2018):336-342.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:45 下载次数:0
浏览次数:45
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部